Perry C. Siatis - Apr 3, 2023 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role: EVP, GC AND SECRETARY
Signature: Steven L. Scrogham, attorney-in-fact for Perry C. Siatis
Stock symbol: ABBV
Transactions as of: Apr 3, 2023
Transactions value $: -$563,200
Form type: 4
Date filed: 4/5/2023, 05:00 PM
Previous filing: Mar 2, 2023
Next filing: Feb 6, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABBV	Common Stock, $0.01 par value	Options Exercise	$373K	+3.52K	+33.92%	$105.92	13.9K	Apr 3, 2023	Direct
transaction	ABBV	Common Stock, $0.01 par value	Sale	-$563K	-3.52K	-25.33%	$160.00	10.4K	Apr 3, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABBV	Option (Right to buy)	Options Exercise	-$373K	-3.52K	-50%	$105.92	3.52K	Apr 3, 2023	Common Stock	3.52K	$105.92	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).